Skip to content

Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01101711
Enrollment
50
Registered
2010-04-12
Start date
2006-11-30
Completion date
2012-09-30
Last updated
2012-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarctions, Endocrine Dysfunction, Quality of Life

Brief summary

Investigation of the incidence of endocrine dysfunction following subarachnoid hemorrhage (SAH), and to see if this has a relation to CNS lesions as evaluated by MRI and to common symptoms after SAH such as general exhaustion, lack of initiative, increased sleep demand and reduced quality of life.

Interventions

None listed

Sponsors

Lund University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute aneurysmal subarachnoid hemorrhage

Exclusion criteria

* unable to give informed consent

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026